Work

Phase I evaluation of the safety of conatumumab (AMG 655) in combination with AMG 479 in patients (pts) with advanced, refractory solid tumors.

Year: 2010

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2010.28.15_suppl.3102

Authors: S. P. Chawla, J. Tabernero, H. L. Kindler, E. G. Chiorean, P. LoRusso, M. Hsu, V. Haddad, B. A. Bach, J. Baselga

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2245304602

Cites:

Cited by: 14

Related to: 10